Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature

Ann Otol Rhinol Laryngol. 2012 May;121(5):291-5. doi: 10.1177/000348941212100502.

Abstract

Objectives: Posttransplant lymphoproliferative disorder (PTLD) is a well-recognized complication of solid organ transplantation and commonly affects upper airway lymphoid tissue. Tracheal and laryngeal involvement in patients with PTLD, however, is rare. We present one such case.

Methods: We report the case of a patient with recurrent PTLD involving the larynx and trachea and describe the presentation, evaluation, management, and outcome.

Results: An 11-year-old boy who underwent bilateral nephrectomy and renal transplantation as an infant was admitted to the hospital with chronic cough, fever, stridor, and dyspnea. His post-transplantation course was complicated by PTLD in cervical lymph nodes at 9 years of age that was successfully treated with chemotherapy. A computed tomographic scan during his present admission revealed supraglottic swelling, a distal tracheal mass, and paratracheal lymph node enlargement. The patient underwent laryngoscopy and bronchoscopy with biopsy specimens taken from the right laryngeal ventricle and distal trachea. Pathologic examination yielded a diagnosis of Epstein-Barr virus-positive PTLD. The patient was treated with chemotherapy, which resulted in resolution of the airway lesions, as seen on repeat bronchoscopy.

Conclusions: This is the first report, to our knowledge, of recurrent PTLD involving simultaneous lesions in the larynx and the trachea. PTLD in the head and neck can present as lymphoid hypertrophy, airway obstruction, stridor, or cough. A high degree of clinical suspicion is essential for prompt diagnosis of this life-threatening complication.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Airway Obstruction / etiology
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bronchoscopy
  • Child
  • Cyclophosphamide / administration & dosage
  • Epstein-Barr Virus Infections / complications*
  • Epstein-Barr Virus Infections / diagnosis
  • Epstein-Barr Virus Infections / drug therapy
  • Glucocorticoids / administration & dosage
  • Herpesvirus 4, Human* / isolation & purification
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation / adverse effects*
  • Larynx / pathology*
  • Larynx / virology
  • Lymphoproliferative Disorders / diagnosis
  • Lymphoproliferative Disorders / drug therapy
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / virology
  • Male
  • Nephrectomy
  • Recurrence
  • Rituximab
  • Trachea / pathology*
  • Trachea / virology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide